您的位置:首页 > 产品中心 > KARPAS 231
KARPAS 231
产品别名
KARPAS 231
KARPAS, 231
产品性质
biological source【生物来源】 | human blood (leukemia) |
growth mode【生长模式】 | Suspension |
karyotype【核型】 | Not specified |
morphology【形态学】 | Single round to polymorphic cells growing in suspension |
products【产品】 | Not specified |
receptors【受体】 | Not specified |
technique(s) | cell culture | mammalian: suitable |
relevant disease(s)【相关疾病】 | cancer |
shipped in【运输】 | dry ice |
基本信息
Cell Line Origin【细胞系来源】 | Human B-cell leukemia |
Cell Line Description【细胞系描述】 | Established from peripheral blood of a 71 year-old woman at diagnosis of B-cell acute lymphoblastic leukemia (ALL). No rearrangement of C-MYC DNA sequences. |
DNA Profile【DNA图谱分析】 | Not specified |
Culture Medium【培养基】 | RPMI 1640 + 2 mM Glutamine + 10% Fetal Bovine Serum (FBS). |
Subculture Routine【传代培养常规】 | Maintain cultures between 0.5 - 2 x1000,000 cells/ml; 5% CO2; 37 ℃. Doubling time approximately 60 hours. Split saturated culture 1:2 every 2-4 days. Cells are single round to polymorphic and grow in suspension. |
Other Notes【其他说明】 | Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information. |
产品说明
Disclaimer【免责声明】 | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |